info@example.com

+1 66589 14556

Prostate Biopsy Explained

Prostate Biopsy Explained

📖 10 min read Written/reviewed by Dr. Alhad Naragude, MBBS, MS, DrNB Urology Last updated: September 6, 2026

A prostate biopsy is a test where small tissue samples are taken from the prostate gland to check for prostate cancer. It may be advised if PSA is repeatedly high, prostate MRI shows a suspicious PI-RADS lesion, or the prostate feels abnormal on examination. A biopsy does not mean you definitely have cancer. It answers three important questions: Is cancer present? How aggressive does it look? What should be done next? The fear before biopsy is often worse than the procedure itself. With proper selection, anaesthesia, infection precautions and follow-up, it is usually a short day-care test.

The most important point first: not every high PSA needs biopsy

A single PSA value should not automatically lead to biopsy. PSA can rise with benign prostate enlargement, urine infection or prostatitis, acute urinary retention, recent ejaculation and prostate manipulation or procedures. A smooth urinary catheter alone usually has little effect. PSA trend, prostate size, examination, MRI and individual cancer risk should be considered together.

So the decision is not simply: PSA high, do biopsy. A careful urology evaluation looks at PSA trend, prostate size, urine infection, MRI findings, rectal examination, family history, age, general health and whether the biopsy result will actually change treatment.

What is a prostate biopsy?

A prostate biopsy is a diagnostic procedure. A urologist uses a special needle to take thin tissue cores from the prostate. These samples are examined by a pathologist under a microscope.

The biopsy does not remove the prostate. It is not a treatment. It does not spread cancer. Its job is to confirm whether cancer cells are present, which area is involved, how many cores contain cancer, how aggressive the cancer looks and whether monitoring, surgery, radiation or further staging is needed.

Current EAU guidance recommends prostate MRI before biopsy in most men with suspected organ-confined prostate cancer when MRI is available and appropriate. MRI helps identify suspicious areas, estimate risk and guide targeted sampling; in selected low-risk men it can support avoiding immediate biopsy.

Simple prostate biopsy decision flow

Step What is checked Why it matters
1. Confirm PSA context Infection, catheter, retention or recent procedure Avoids unnecessary biopsy
2. Support PSA if needed Repeat PSA, free PSA, PSA density Helps judge true risk
3. Examine prostate Digital rectal examination Detects hard nodules or asymmetry
4. MRI prostate PI-RADS score, lesion location, prostate size Helps decide need and target
5. Decide biopsy type Transperineal/transrectal, targeted/systematic Improves safety and accuracy
6. Interpret report Gleason score, Grade Group, positive cores Guides treatment or surveillance

This is why a biopsy decision should feel like a reasoned plan, not a reflex reaction to one number.

Why is prostate biopsy done?

Your urologist may advise prostate biopsy if you have:

  • Persistently high PSA.
  • PSA that is rising over time.
  • High PSA density, meaning PSA is high compared with prostate size.
  • Suspicious MRI prostate lesion, especially PI-RADS 4 or 5.
  • PI-RADS 3 lesion with other risk factors.
  • Hardness, nodule or asymmetry on rectal examination.
  • Previous negative biopsy but continuing suspicion.
  • Known low-risk prostate cancer under active surveillance.

A biopsy is also sometimes needed before deciding whether a patient is suitable for active surveillance, surgery, radiation or focal treatment.

When biopsy may be delayed or avoided

Biopsy may need to be postponed if you have:

  • Active urine infection or fever.
  • Uncontrolled diabetes.
  • An unresolved blood thinner issue.
  • Recent catheterisation or urine retention.
  • Recent prostate surgery.
  • Poor fitness for anaesthesia, if anaesthesia is planned.

Biopsy may be avoided or deferred if MRI is low-risk, PSA density is reassuring, examination is normal and the overall risk is low. In elderly or medically fragile patients, biopsy is considered only if the result is likely to change management. This is not neglect. This is good clinical judgment.

Types of prostate biopsy

Type How it is done Practical meaning
Transperineal biopsy Needle passes through the skin between scrotum and anus Lower infection risk; increasingly preferred where available
Transrectal biopsy / TRUS biopsy Needle passes through rectal wall into prostate Common and quick; needs careful antibiotic precautions
MRI-targeted biopsy Suspicious MRI area is specifically sampled Useful for PI-RADS lesions
Systematic biopsy Standard zones of prostate are sampled Helps find cancer outside visible MRI lesion
Fusion biopsy MRI image is fused with live ultrasound Better targeting for small or difficult lesions

When MRI is suspicious, biopsy targets the lesion. Additional perilesional or systematic sampling depends on the PI-RADS score, whether this is a first or repeat biopsy, PSA density and local protocol; it is not identical for every patient.

Transperineal vs transrectal biopsy

Both methods can diagnose prostate cancer. The difference is the route. In transrectal biopsy, the needle passes through the rectum into the prostate, so antibiotic precautions are important. In transperineal biopsy, the needle passes through cleaned skin between the scrotum and anus. This avoids passing the needle through rectal bacteria.

European infection guidance reports lower infectious complications with the transperineal route and strongly recommends it because of lower infection risk. However, the best method also depends on availability, MRI findings, anaesthesia setup, patient comfort, prostate size, cost and local expertise.

How to prepare for prostate biopsy

Before biopsy, tell your urologist if you:

  • Take aspirin, clopidogrel, warfarin, apixaban, rivaroxaban or dabigatran.
  • Have diabetes, heart disease, kidney disease or liver disease.
  • Have a pacemaker, heart valve, cardiac stent, joint replacement or vascular graft.
  • Had fever or sepsis after a previous biopsy or urinary procedure.
  • Are allergic to antibiotics, local anaesthetic, iodine or antiseptic solution.
  • Recently had catheterisation, cystoscopy, TURP or prostate surgery.

Do not stop blood thinners on your own. Your urologist may coordinate with your physician or cardiologist. You may be asked for urine routine, urine culture, creatinine, CBC, coagulation profile, PSA records and MRI prostate report.

What happens during prostate biopsy?

Most prostate biopsies are day-care procedures. Some are done under local anaesthesia. Some patients may need sedation, spinal anaesthesia or general anaesthesia.

During the procedure:

  • Your history, medicines and consent are reviewed.
  • You are positioned safely.
  • The area is cleaned with antiseptic.
  • Ultrasound is used to see the prostate.
  • Local anaesthetic is given.
  • Samples are taken from suspicious MRI areas and/or standard prostate zones.
  • You are observed for bleeding, dizziness or urine difficulty.
  • You usually go home the same day.

Is prostate biopsy painful?

Most men describe prostate biopsy as uncomfortable, not severely painful. You may feel pressure from the ultrasound probe, a brief sting from local anaesthetic and a clicking sound when samples are taken.

Tell your urologist beforehand if you are very anxious, have piles, fissure, anal pain, previous painful biopsy, a large prostate or difficulty lying in position. Anaesthesia can be adjusted.

What is normal after prostate biopsy?

After biopsy, it can be normal to have:

  • Mild blood in urine for a few days.
  • Blood in semen for a few weeks.
  • Mild burning while passing urine.
  • Perineal or rectal soreness.
  • Small clots occasionally.
  • Tiredness on the day of biopsy.

Drink enough water unless your doctor has restricted fluids. Avoid heavy lifting, cycling, gym workouts, straining and long travel for a short period as advised.

Risks of prostate biopsy

  • Blood in urine, semen or stool.
  • Infection or fever.
  • Temporary difficulty passing urine.
  • Acute urinary retention.
  • Clot retention.
  • Pain or bruising.
  • Rare hospital admission.
  • Need for repeat biopsy if results are inconclusive.
Important: Fever, chills or shivering after prostate biopsy should not be ignored. Seek urgent medical care, especially if fever occurs with weakness, burning urine, low urine output or worsening pain.

Emergency signs after prostate biopsy

Seek urgent medical care if you have:

  • Fever, chills or shivering.
  • Inability to pass urine.
  • Heavy bleeding or large clots.
  • Severe pain not improving.
  • Dizziness, confusion or weakness.
  • Burning urine with fever.
  • Very low urine output.
  • Symptoms worsening instead of gradually improving.

What does the prostate biopsy report mean?

Report term Meaning
Benign No cancer seen in sampled tissue
Prostatitis Inflammation of the prostate
HGPIN Abnormal prostate cells; may need follow-up depending on context
ASAP Suspicious glands, but not enough to confirm cancer
Adenocarcinoma Commonest type of prostate cancer
Gleason score Microscopic grading of cancer pattern
Grade Group Simpler cancer risk group from 1 to 5
Positive cores Number of samples containing cancer
Core involvement How much of each core contains cancer
Perineural invasion Cancer seen around small nerves; interpreted with other factors

A biopsy report is never interpreted in isolation. It is combined with PSA, MRI stage, prostate size, examination, age, urinary symptoms and general fitness.

Gleason score and Grade Group made simple

Grade Group Common Gleason score Usual meaning
Grade Group 1 3+3=6 Low grade; often slow-growing
Grade Group 2 3+4=7 Favourable intermediate risk in many cases
Grade Group 3 4+3=7 More concerning than 3+4
Grade Group 4 8 High-risk features
Grade Group 5 9-10 Highest-grade group

A very important detail: Gleason 3+4 and 4+3 are both 7, but they are not equal. In 3+4, the less aggressive pattern is dominant. In 4+3, the more aggressive pattern is dominant. That difference can change treatment planning.

If biopsy is negative, is cancer ruled out?

A negative biopsy is reassuring, but it does not always end follow-up. A small cancer can occasionally be missed, especially if PSA continues rising or MRI remains suspicious.

After a negative biopsy, your urologist may advise:

  • Repeat PSA after 3-6 months.
  • PSA density calculation.
  • Repeat MRI.
  • Review of MRI films by an experienced radiologist.
  • Repeat targeted biopsy if suspicion remains.
  • Observation if overall risk is low.

If cancer is found, what happens next?

Finding prostate cancer does not always mean immediate surgery. Some prostate cancers are slow-growing and can be safely monitored with active surveillance, especially selected low-volume Grade Group 1 cancers.

Depending on risk, options may include:

  • Active surveillance.
  • Radical prostatectomy.
  • Radiation therapy.
  • Hormone therapy.
  • Further staging scans such as PSMA PET-CT, CT, MRI or bone scan.
  • Combined treatment for higher-risk disease.

This is why biopsy is useful. It does not only say cancer or no cancer. It tells the urologist whether the safest next step is monitoring, local treatment or more detailed staging.

Questions to ask before biopsy

  • Why do I need biopsy now?
  • Is my MRI suspicious? What is the PI-RADS score?
  • What is my prostate size and PSA density?
  • Can biopsy wait if infection, retention or recent instrumentation affected PSA?
  • Will biopsy be transperineal or transrectal?
  • Will it be MRI-targeted, systematic or both?
  • What should I do about blood thinners?
  • What infection precautions will be used?
  • When will the report come?
  • If biopsy is negative, what is the follow-up plan?
  • If cancer is found, will all options be discussed?

Consultation checklist

  • PSA reports with dates.
  • Free PSA/total PSA, if done.
  • MRI prostate report and films/CD.
  • USG prostate size and post-void residual urine report.
  • Urine routine and urine culture.
  • Creatinine, CBC and coagulation reports, if available.
  • List of medicines, especially blood thinners.
  • Diabetes, BP and cardiac records.
  • Previous biopsy, TURP, catheter or prostate surgery records.
  • Family history of prostate, breast, ovarian or pancreatic cancer.

FAQs

Is prostate biopsy necessary for every high PSA?

No. PSA can rise due to benign enlargement, infection or prostatitis, acute urinary retention and recent prostate procedures. A smooth catheter alone usually has little effect. Biopsy is considered only after the full risk picture—PSA trend, prostate size/PSA density, MRI, examination and individual risk factors—is reviewed.

Can MRI replace prostate biopsy?

MRI can reduce unnecessary biopsy in selected patients, but it cannot confirm cancer by itself. Cancer diagnosis still needs tissue confirmation when suspicion is significant.

Which is safer: transperineal or transrectal biopsy?

Transperineal biopsy generally has a lower infection risk because the needle does not pass through the rectal wall. The best approach depends on patient factors, centre expertise and availability.

Can prostate biopsy spread cancer?

No. Prostate biopsy does not spread prostate cancer.

How long does the biopsy report take?

In many centres, the report takes about 5-10 days. Additional review may take longer.

Is blood in semen after biopsy dangerous?

Usually no. Blood in semen is common and may persist for several weeks. It can look alarming, but it usually settles on its own.

What if my biopsy shows Grade Group 1 cancer?

Grade Group 1 prostate cancer is often slow-growing. Many patients may be suitable for active surveillance, depending on PSA, MRI, number of positive cores, percentage involvement, age and preference.

Related reading

References

Note: This information is for educational purposes only and is not a substitute for medical advice. Please consult your doctor for any symptoms.